ERA-NET for Industrial Biotechnology: Since 2006, a network of European funders and associated states have worked together to reduce fragmentation in national research efforts in Europe and to foster the exchange of knowledge across borders via joint transnational calls. ERA-IB-2 built on the success of the FP6 project “ERA-IB” and developed the network further, into a truly pan-European approach to IB R&D funding. ERA-IB-2 ran between 12/2011 and 05/2016 with a total of 19 partners from 15 countries, coordinated by FNR.
Up to today, 71 projects with project partners from 17 countries have been funded in 7 joint calls in the frame of ERA-IB and ERA-IB-2 with a total funding of over 90 million €.
The general evaluation by the researchers about the opportunities ERA-IB-2 offered, highlighted the benefits of international cooperation, the exchange of knowledge across borders and disciplines, the chances to investigate multiple production systems in parallel and the challenging project tasks that could not be carried out without the partners complimentary expertise and specialised techniques.
A high number of scientific papers in high impact journals, many publications, researcher exchanges, posters and presentations at international conferences as well as a participation in Marie Sklodowska Curie Innovative Training Network (ITN) further emphasized the outputs/benefits of the network.
In the future the majority of the ERA-IB funders network join forces with funders from the ERA-NETs for Systems Biology and Synthetic Biology to work together in the “ERA-NET CoFund on Biotechnologies”. Besides a big call cofunded by the EC, it is envisaged to continue with annual calls for the next 5 years which allow for many more exciting new IB projects which contribute to secure Europe’s competitiveness in the field of Industrial Biotechnology.
This project received funding from the European Union’s Seventh Programme for research, technological development and demonstration under grant agreement No 291814.